| dc.contributor.author | Sundar, S | |
| dc.contributor.author | Manchanda, R | |
| dc.contributor.author | Gourley, C | |
| dc.contributor.author | Ganesan, R | |
| dc.date.accessioned | 2021-01-15T18:09:23Z | |
| dc.date.available | 2020-12-09 | |
| dc.date.available | 2021-01-15T18:09:23Z | |
| dc.identifier.issn | 1048-891X | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/69786 | |
| dc.publisher | BMJ Publishing Group | en_US |
| dc.relation.ispartof | International Journal of Gynecological Cancer | |
| dc.title | British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumour testing for BRCA1/2 variants in ovarian cancer in the United Kingdom | en_US |
| dc.type | Article | en_US |
| dc.rights.holder | © IGCS and ESGO 2021. No commercial re-use. Published by BMJ. | |
| dc.identifier.doi | 10.1136/ijgc-2020-002112 | |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Accepted | en_US |
| pubs.publisher-url | https://ijgc.bmj.com/content/early/2021/01/18/ijgc-2020-002112 | |
| dcterms.dateAccepted | 2020-12-09 | |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| atmire.cua.enabled | Sundar S, Manchanda R, Gourley C, et al. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom. International Journal of Gynecologic Cancer. Published Online First: 19 January 2021. doi: 10.1136/ijgc-2020-002112 | |
